Clinical research uses human volunteers to add to medical knowledge. Clinical research includes trials that test new treatments and therapies, genetic studies to explore ways in which a person’s genes may contribute to developing a disorder and epidemiological studies to understand the patterns, causes, and effects of health and disease.
Clinical Trials
Human clinical trials are a critical phase to bringing safe and effective treatments to market. Many tests are conducted before the clinical trial stage to determine whether potential treatments are appropriate for testing in people. It is through clinical trials that safe and effective drugs, therapies and potentially, a cure for alopecia areata will be discovered.
By participating in a clinical trial, you play an important role in the effort to develop effective treatments for alopecia areata. The decision to participate is very personal and should be made only after speaking with your health care provider and other individuals you trust. You can stop participation in a clinical trial at any time if new concerns arise or you lose confidence that its potential benefits outweigh its risks.
Clinical Trial Resources
ClinicalTrials.gov is a resource from the U.S. National Library of Medicine that offers up-to-date information for locating federally and privately supported clinical trials for a wide range of diseases and conditions. Visit ClinicalTrials.gov to review clinical trials that are recruiting particpants for studies on alopecia areata and other diseases.
Watch a webinar to learn more about clinical trials and how to search on ClinicalTrials.gov.
Download our guide to using ClinicalTrials.gov.
Download our worksheet, Clinical Trials and You, with questions to ask your doctor.
The National Alopecia Areata Foundation is committed to delivering accurate and reliable information to everyone affected by alopecia areata, and subsequently reviews many requests for postings about participation in research studies. The following is a current list of clinical trials and research studies working with NAAF to recruit people with alopecia areata for particpation.
Disclaimer: NAAF provides research notices as an informational service to its community. NAAF is not conducting the study. This information does not represent a NAAF endorsement, but rather makes you aware that clinical studies are available for your participation if you choose. If you are presently under the care of a physician for alopecia areata, or other conditions, you should discuss clinical trial particpation with your doctor before altering your treatment program. NAAF is not responsible for any adverse outcomes.
Age 18 to 63 years of age; severe patchy hair loss from alopecia areata
Age 6-17; diagnosed with alopecia areata (30% or greater scalp hair loss)
Age 18 years or older; definitive diagnosis of AA of more than 6 months; diagnosis of severe AA, as determined by 50% or greater scalp hair loss, current episode of hair loss < 8 years, and no evidence of hair regrowth within 6 months; willingness in maintaining consistent hair style and hair care
Age at least 18 years ≤60 years for males or ≤70 years of age for females; diagnosis of severe to very severe AA with ≥ 50% scalp hair loss; current episode of severe to very severe AA of less than 8 years
18 years or older; diagnosed with alopecia areata; about to start an oral JAK inhibitor; able to travel to UCSF for two in-person study visits
Age 18 years or older; history of at least 6 months of moderate to severe AA (≥ 50% scalp involvement); screening IgE > 200 and/or personal and/or familial history of atopy
18 to 70 years of age; patchy AA with 30% to 80% scalp hair loss
Age 2 and up; diagnosis of immune-mediated alopecia
6 years to 17 years at the age of consent (enrollment will be fully sequential by age group, with adolescents (12 to less than 18 years old) enrolling before children (6 to less than 12 years old)
18 years or older; diagnosed with alopecia areata; no history of heart attack or stroke
